Informations actualisées sur le dépistage prénatal précoce en 2025
Résumé
Les progrès réalisés en matière de dépistage prénatal au cours des trois dernières décennies ont permis de développer des méthodes axées sur la génétique, le bien-être fœtal et le dépistage de la prééclampsie. Ces avancées offrent des informations précoces pendant la grossesse, favorisant une meilleure gestion des risques et des stratégies de planification adaptées.
Références
Penrose LS. The relative effects of paternal and maternal age in Down’s Syndrome. J. Genet. 2009 Apr; 88(1): 9-14. Available from: https://jhanley.biostat.mcgill.ca/StatisticalSudoku/Penrose1933.pdf
Tjio JH, Levan A. The chromosome number of man. Hereditas.1956;42:1-6. https://doi.org/10.1111/j.1601-5223.1956.tb03010.x
Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ. 1992;304(6831):867-869. doi:10.1136/bmj.304.6831.867
Cicero S, Avgidou K, Rembouskos G, Kagan KO, Nicolaides KH. Nasal bone in first-trimester screening for trisomy 21. Am J Obstet Gynecol. 2006;195(1):109-114. doi:10.1016/j.ajog.2005.12.057
Maiz N, Valencia C, Kagan KO, Wright D, Nicolaides KH. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol. 2009;33(5):512-517. doi:10.1002/uog.6330
Savoia F, Scala C, Coppola M, Riemma G, Vitale SG, Mikus M, et al. The diagnostic performance of the ductus venosus for the detection of cardiac defects in the first trimester: a systematic review and diagnostic test accuracy meta-analysis. Arch Gynecol Obstet. 2023;308(2):435-451. doi:10.1007/s00404-022-06812-w
The Fetal Medicine Foundation. Welcome to the Fetal Medicine Foundation [Internet]. 2025; [cited 16 May 2025]. Available from: https://fetalmedicine.org/
Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargen LL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350(9076):485-487. doi:10.1016/S0140-6736(97)02174-0
Yin L, Tang Y, Lu Q, Shi M, Pan A, Chen D. Noninvasive prenatal testing detects microdeletion abnormalities of fetal chromosome 15. J Clin Lab Anal. 2019;33(6):e22911. doi:10.1002/jcla.22911
World Health Organization. Pre-eclampsia [Internet]. 2025; [updated 4 April 2025, cited 16 May 2025]. Available from: https://www.who.int/news-room/fact-sheets/detail/pre-eclampsia#:~:text=Key%20Facts%20*%20Pre%2Declampsia%20affects%202%E2%80%938%%20of,and%20Africa%2C%20and%2025%%20in%20Latin%20America
Rolnik DL, Wright D, Poon LCY, Syngelaki A, O’Gorman N, de Paco Matallana C, et al. ASPRE trial: performance of screening for preterm pre-eclampsia [published correction appears in Ultrasound Obstet Gynecol. 2017 Dec;50(6):807. doi: 10.1002/uog.18950.]. Ultrasound Obstet Gynecol. 2017;50(4):492-495. doi:10.1002/uog.18816
International Federation of Gynecology and Obstetrics. Predicting and preventing pre-eclampsia: the challenge [Internet].2019; [Cited 16 May 2025]. Available from: https://www.figo.org/figo-releases-new-guidelines-combat-pre-eclampsia
ObG Project. How many anomalies missed by NIPT are identified with first trimester ultrasound [Internet]? 2023; [Cited 16 May 2025]. Available from: https://www.obgproject.com/2023/09/19/how-many-anomalies-missed-by-nipt-are-identified-with-first-trimester-ultrasound/
Publié
Comment citer
Numéro
Rubrique
Licence
© Canadian Primary Care Today 2025
Cette œuvre est sous licence Creative Commons Attribution - Pas d'Utilisation Commerciale - Pas de Modification 4.0 International.
